As shown in Figure 2, the results of 9 studies involving 1839 cancer patients demonstrated that high KIF2A expression was significantly related to a shorter OS (HR = 2.23, 95% CI = 1.87–2.65, P < .001). This evidence concerns the gene KIF2A and cancer.